In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.
All content for Phase Forward is the property of Podcast Series hosted by Valerie Coveney and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.
Episode 22: Enhancing Clinical Trial Efficiency: 3 Essential CTMS Tips for Sponsors, CROs, and Sites
Phase Forward
11 minutes 18 seconds
8 months ago
Episode 22: Enhancing Clinical Trial Efficiency: 3 Essential CTMS Tips for Sponsors, CROs, and Sites
Robert Taylor, Associate Director of Clinical Operations at Innovaderm, joins us in an episode of Phase Forward. He shares his top 3 tips for improving clinical trial efficiency with CTMS. Learn how centralized data management, process automation, and remote monitoring tools can lower costs and enhance data quality. Perfect for sponsors, CROs, and sites looking to optimize their trials.
Phase Forward
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.
